Thursday, June 30, 2016

Gene complex predicts ovarian cancer survival

Richard Morgan is the Director of the University of 
Bradford's Institute of Cancer Therapeutics in the UK
Image courtesy of U of Bradford
CANCER DIGEST  – June 29, 2016 – A new British study has identified a genetic marker that predicts poor survival from ovarian cancer. In addition, the study also identified a set of genes that help the cancer develop resistance to chemotherapy.

The study, published in the International Journal of Cancer, examined the role of HOX genes in ovarian cancer resistance to chemotherapy and whether a drug known as HXR9, which targets HOX, could help prevent the resistance from developing.

Wednesday, June 22, 2016

Navigators improve cancer screening rates

Copyright: Andose, used under license 123rf
CANCER DIGEST – June 22, 2016 – Having a navigator is an ancient method of ensuring you get where you want to go. It appears it is no less true when it comes to navigating the complex US healthcare system.

A new study by the Massachusetts General Hospital (MGH) shows that patients who had navigators, individuals who assist patients in receiving healthcare services, may improve comprehensive cancer screening rates among patients who are not likely to seek recommended screenings.

Sunday, June 19, 2016

Mid-life PSA test predicts prostate cancer death

CANCER DIGEST – June 19, 2016 – A single PSA test in midlife can predict future prostate cancer death a study in the June 13, 2016 Jounal of Clinical Oncology concludes. 

Led by Mark Preston, MD, MPH, the Brigham and Women’s Hospital study started in 1982 followed more than 22,000 male physicians aged 40 to 59 who gave blood before being randomly assigned to groups, one taking aspirin and beta carotene the other given a placebo.

Tuesday, June 7, 2016

Universal cancer vaccine can attack any cancer

CANCER DIGEST – June 7, 2016– German scientists have reported inching closer to a long sought universal vaccine that will attack cancer, any cancer.

Research groups around the world for decades have been pursuing the vaccine approach, which will rev up a cancer patient’s immune system to recognize and eliminate cancer cells.